KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Shares Outstanding (Diluted Average) (2016 - 2025)

Charles River Laboratories International (CRL) has 10 years of Shares Outstanding (Diluted Average) data on record, last reported at $49.6 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 4.0% year-over-year to $49.6 million; the TTM value through Dec 2025 reached $49.6 million, down 4.0%, while the annual FY2025 figure was $49.6 million, 4.0% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $49.6 million in Q4 2025 per CRL's latest filing, roughly flat from $49.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $51.8 million in Q2 2024 and bottomed at $49.3 million in Q2 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $51.1 million, with a median of $51.4 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 2.43% in 2021, then dropped 4.88% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $51.4 million in 2021, then dropped by 0.24% to $51.3 million in 2022, then rose by 0.29% to $51.5 million in 2023, then grew by 0.34% to $51.6 million in 2024, then dropped by 4.0% to $49.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $49.6 million in Q4 2025, $49.4 million in Q3 2025, and $49.3 million in Q2 2025.